COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Long-Term Follow-Up Safety Monitoring of Patients Dosed in the First-in-Man Phase I/II Study of TT-034.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02315638
Recruitment Status : Terminated (Long term safety follow-up no longer required)
First Posted : December 12, 2014
Last Update Posted : September 26, 2018
Information provided by (Responsible Party):
Tacere Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : September 24, 2018
Actual Study Completion Date : September 24, 2018